Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease

doi:10.3748/wjg.v22.i44.9734

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 44

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9648)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

575

WORD

335

HTML

3912

Figures (1-7)

373

Tables (1-4)

361

Sum=5556

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1163

Download

2929

Sum=4092

Nov 28, 2016 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Nov 28, 2016; 22(44): 9734-9743
Published online Nov 28, 2016. doi: 10.3748/wjg.v22.i44.9734

Full Size Figure Download Figure

Figure 5 Representative trend of cytokine secretion after muramyl dipeptide stimulation, with live bacteria. Variation trend of IL6 secretion after muramyl dipeptide (MDP) stimulation in patients suffering from active Crohn’s disease (CD), active ulcerative colitis (UC) and healthy controls (HC), in absence of antibiotics [live bacteria (LB)]. No statistical significance was found.

Citation: Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A. Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease. World J Gastroenterol 2016; 22(44): 9734-9743
URL: https://www.wjgnet.com/1007-9327/full/v22/i44/9734.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i44.9734